Immunology

Breakthrough may explain why cancer immunotherapies can backfire

Research by University of Alberta scientists into PD-1, a cell surface receptor that naturally plays a major role in de-escalating the body's immune system, may explain why it can go haywire and cause autoimmune diseases ...

Oncology & Cancer

Hunting for immune cells' cancer targets

By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two patients with colorectal cancer.

Immunology

Better cancer immunotherapy drugs through X-ray crystallography

Immunotherapy drugs to combat cancer have stimulated tremendous excitement among patients and physicians alike. They debuted in 2011, when the U.S. Food and Drug Administration approved ipilimumab (Yervoy) to treat metastatic ...

page 21 from 26